Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

Mass High Tech Quotes Harry Glorikian in Article on "Mass. drug companies drawing Japanese interest"

Julie M. Donnelly
October 1, 2010

Following the sale of Marlborough-based Sepracor Inc. to Japanese drug maker Dainippon Sumitomo Pharma, Julie M. Donnelly of Mass High Tech quotes Harry Glorikian, Scientia Advisors' Managing Partner, in an article commenting on Japanese drug makers' increasing investment in Massachusetts life science companies. According to Mr. Glorikian "Japanese firms need to expand their reach into the United States to keep growing."

Read the full article at: Mass High Tech